1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical EvaluationAdenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumorActive, not recruitingNot stated2026-09-16NCT07817225